| scholarly article | Q13442814 |
| P2093 | author name string | LANCEFIELD RC | |
| R. C. LANCEFIELD | |||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 307-313 | |
| P577 | publication date | 1962-09-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Current knowledge of type-specific M antigens of group A streptococci | |
| P478 | volume | 89 |
| Q24650424 | A cluster of cases of streptococcal necrotizing fasciitis in Gloucestershire |
| Q37010316 | A highly conserved region present in transcripts encoding heterologous M proteins of group A streptococci. |
| Q37007120 | A method for allelic replacement that uses the conjugative transposon Tn916: deletion of the emm6.1 allele in Streptococcus pyogenes JRS4. |
| Q30377731 | A molecular trigger for intercontinental epidemics of group A Streptococcus. |
| Q36959411 | A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci |
| Q33992290 | A response regulator that represses transcription of several virulence operons in the group A streptococcus |
| Q37153496 | Acid-Precipitated M Protein Compared with a Column-Eluted M Protein Preparation from Type 12, Group A Streptococci |
| Q37179799 | Acrylamide Gel Electrophoresis of Group A Streptococcal Cell Walls |
| Q35387834 | Adult and pediatric pharyngitis: a review |
| Q24655229 | Amide bonds assemble pili on the surface of bacilli |
| Q37339264 | Amino acid sequence and physicochemical similarities between streptococcal M protein and mammalian tropomyosin |
| Q34483813 | An antiphagocytic factor associated with group E streptococcus |
| Q35473131 | Anti-Hsp65 antibodies recognize M proteins of group A streptococci |
| Q33369063 | Antibodies against a surface protein of Streptococcus pyogenes promote a pathological inflammatory response |
| Q34006819 | Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci |
| Q40732564 | Anticapsin, a New Biologically Active Metabolite: Screening and Assay Procedures |
| Q36351514 | Antigenic domains of the streptococcal Pep M5 protein. Localization of epitopes crossreactive with type 6 M protein and identification of a hypervariable region of the M molecule |
| Q40786508 | Antigenic type-specificity of swine isolates of Streptococcus equisimilis |
| Q42831956 | Antigenicity of the M proteins of group A hemolytic streptococci. 3. Antibody responses and cutaneous hypersensitivity in humans |
| Q34388856 | Antigenicity of the M proteins of group A hemolytic streptococci: further evidence for shared determinants among serotypes |
| Q40680963 | Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci |
| Q33558301 | Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. |
| Q36115416 | Architecture of the vir regulons of group A streptococci parallels opacity factor phenotype and M protein class |
| Q36355993 | Autoimmune sequence of streptococcal M protein shared with the intermediate filament protein, vimentin |
| Q41991832 | Bacteriophage control of antiphagocytic determinants in group A streptococci |
| Q72772010 | Binding ability of complement receptor CR1 to C3 bound on the surface of M+ group A streptococci |
| Q36278267 | Biochemical and biological properties of the binding of human fibrinogen to M protein in group A streptococci |
| Q37016911 | Biological and immunochemical identity of M protein on group G streptococci with M protein on group A streptococci |
| Q24650974 | Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response |
| Q54731662 | Cell surface proteins of a group A streptococcus type M4: the IgA receptor and a receptor related to M proteins are coded for by closely linked genes. |
| Q33583725 | Characterization of a new protective antigen of Streptococcus canis |
| Q36821975 | Chemistry and end-group analysis on purified M protein of type 12 group A streptococcal cell walls |
| Q39706987 | Cleavage of antigen-bound immunoglobulin G by SpeB contributes to streptococcal persistence in opsonizing blood |
| Q35096925 | Cloning and expression of the streptococcal C5a peptidase gene in Escherichia coli: linkage to the type 12 M protein gene |
| Q36277411 | Coagulases as determinants of protective immune responses against Staphylococcus aureus |
| Q35106098 | Combined contributions of streptolysin O and streptolysin S to virulence of serotype M5 Streptococcus pyogenes strain Manfredo |
| Q42936910 | Common protective antigens of group A streptococcal M proteins masked by fibrinogen |
| Q37055410 | Common themes in microbial pathogenicity |
| Q36005988 | Comparison of the leader sequences of four group A streptococcal M protein genes. |
| Q40737562 | Complement resistance in microbes |
| Q35815193 | Complete Genome Sequences of emm6 Streptococcus pyogenes JRS4 and Parental Strain D471. |
| Q36353164 | Conversion of an M- group A streptococcus to M+ by transfer of a plasmid containing an M6 gene |
| Q36706284 | Cooperative plasminogen recruitment to the surface of Streptococcus canis via M protein and enolase enhances bacterial survival |
| Q40913210 | Correlation of M protein production with those factors found to influence growth and substrate utilization of Streptococcus pyogenes |
| Q34079080 | Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers |
| Q33611935 | Current guidelines for the treatment of patients with rheumatic fever |
| Q24548111 | Cytotoxic effects of streptolysin o and streptolysin s enhance the virulence of poorly encapsulated group a streptococci |
| Q34988307 | Defense from the Group A Streptococcus by active and passive vaccination with the streptococcal hemoprotein receptor |
| Q33374391 | Determination of the mimic epitope of the M-like protein adhesin in swine Streptococcus equi subsp. zooepidemicus |
| Q36698378 | Development of a multicomponent vaccine for Streptococcus pyogenes based on the antigenic targets of IVIG. |
| Q60043983 | Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against |
| Q36353734 | Difference in the structural features of streptococcal M proteins from nephritogenic and rheumatogenic serotypes |
| Q34309446 | Differential recognition of surface proteins in Streptococcus pyogenes by two sortase gene homologs |
| Q34269341 | Differentiation between two biologically distinct classes of group A streptococci by limited substitutions of amino acids within the shared region of M protein-like molecules |
| Q34008545 | Directional gene movement from human-pathogenic to commensal-like streptococci |
| Q54451977 | Domain structure and molecular flexibility of streptococcal M protein in situ probed by limited proteolysis. |
| Q36849214 | Dynamics in Development of Experimental Streptococcal Immunity in Mice |
| Q37416010 | EFFECT OF PARTIALLY PURIFIED STREPTOCOCCAL M PROTEIN ON THE IN VITRO PHAGOCYTOSIS OF STREPTOCOCCUS PYOGENES |
| Q37438318 | EFFECT OF SUBLETHAL CONCENTRATIONS OF PENICILLIN ON THE VIRULENCE AND ANTIGENIC COMPOSITION OF GROUP A STREPTOCOCCI |
| Q40912828 | Effect of Exposure to the Atmosphere on the Infectivity of Group A Streptococci |
| Q39516557 | Effect of penicillin on the humoral and cellular immune response following group A streptococcal pharyngitis |
| Q41521427 | Electron microscopic studies on streptococci. I. M antigen |
| Q39936355 | Environmental regulation of virulence in group A streptococci: transcription of the gene encoding M protein is stimulated by carbon dioxide |
| Q40234715 | Enzyme-linked immunosorbent assay for streptococcal M protein antibodies |
| Q51162242 | Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998-2009): comparison with non-invasive isolates. |
| Q37511196 | Epidemiology and molecular characterization of Streptococcus pyogenes recovered from scarlet fever patients in central Taiwan from 1996 to 1999 |
| Q42940669 | Epithelial cell binding of group A streptococci by lipoteichoic acid on fimbriae denuded of M protein |
| Q36267209 | Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein |
| Q37237107 | Evaluation of Micro Complement Fixation Tests for Antibodies Against Group A Streptococcal M and M-Associated Antigens in Rabbit and Human Sera |
| Q36944865 | Evidence consistent with horizontal transfer of the gene (emm12) encoding serotype M12 protein between group A and group G pathogenic streptococci |
| Q40780228 | Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever |
| Q34955387 | Evolution of sfbI encoding streptococcal fibronectin-binding protein I: horizontal genetic transfer and gene mosaic structure |
| Q36965479 | Expression and immunogenicity of a streptococcal M protein epitope inserted in Salmonella flagellin |
| Q71542841 | Expression of both M protein and hyaluronic acid capsule by group A streptococcal strains results in a high virulence for chicken embryos |
| Q37048393 | Expression of protective and cardiac tissue cross-reactive epitopes of type 5 streptococcal M protein in Escherichia coli |
| Q33637094 | Expression of streptococcal M protein in mammalian cells |
| Q35381699 | Expression of the Arp protein, a member of the M protein family, is not sufficient to inhibit phagocytosis of Streptococcus pyogenes |
| Q35133183 | Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes |
| Q34453021 | Extraction of streptococcal type 12 M protein by cyanogen bromide |
| Q41992297 | FIBRINOGEN PRECIPITATION BY STREPTOCOCCAL M PROTEIN. I. IDENTITY OF THE REACTANTS, AND STOICHIOMETRY OF THE REACTION |
| Q36267450 | FIBROGEN PRECIPITATION BY STREPTOCOCCAL M PROTEIN. II. RENAL LESIONS INDUCED BY INTRAVENOUS INJECTION OF M PROTEIN INTO MICE AND RATS |
| Q35088336 | Fibrinogen binding and resistance to phagocytosis of Streptococcus sanguis expressing cloned M protein of Streptococcus pyogenes |
| Q36331922 | Fibronectin-mediated binding of group A streptococci to human polymorphonuclear leukocytes |
| Q33687454 | Fluorescent amplified-fragment length polymorphism analysis of an outbreak of group A streptococcal invasive disease |
| Q24297754 | Functional and structural properties of a novel protein and virulence factor (Protein sHIP) in Streptococcus pyogenes |
| Q39529596 | Generation and surface localization of intact M protein in Streptococcus pyogenes are dependent on sagA. |
| Q35393989 | Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease |
| Q33750595 | Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs |
| Q34123424 | Genetic instability of M protein and serum opacity factor of group A streptocci: evidence suggesting extrachromosomal control |
| Q39548345 | Genetic studies of Staphylococcus aureus virulence factors |
| Q91666144 | Group A Streptococcus Adsorbed Vaccine: Repeated Intramuscular Dose Toxicity Test in Minipigs |
| Q72317979 | Group A beta-hemolytic streptococcal bacteremia in a patient with sickle cell anemia on penicillin prophylaxis |
| Q33661232 | Group A streptococcal Vir types are M-protein gene (emm) sequence type specific |
| Q37625963 | Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverage |
| Q34701389 | Group A streptococcus expresses a trio of surface proteins containing protective epitopes |
| Q35873177 | Group G streptococcal bacteremia in Jerusalem |
| Q40881484 | Guanidine extraction of streptococcal M protein |
| Q40746320 | Heptad motifs within the distal subdomain of the coiled-coil rod region of M protein from rheumatic fever and nephritis associated serotypes of group A streptococci are distinct from each other: nucleotide sequence of the M57 gene and relation of th |
| Q41159628 | Heterogeneity of group A type-specific antibodies |
| Q34422357 | Homologous and heterologous protection of mice with group A streptococcal M protein vaccines |
| Q36342872 | Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein |
| Q42823779 | Human kininogens interact with M protein, a bacterial surface protein and virulence determinant |
| Q36341947 | Human neutrophil chemotactic response to group A streptococci: bacteria-mediated interference with complement-derived chemotactic factors |
| Q39824807 | Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci |
| Q36444661 | Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages |
| Q24561897 | Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci |
| Q36346371 | Hybridoma antibodies against protective and nonprotective antigenic determinants of a structurally defined polypeptide fragment of streptococcal M protein |
| Q35980281 | Hypervariability generated by natural selection in an extracellular complement-inhibiting protein of serotype M1 strains of group A Streptococcus |
| Q30829613 | IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. |
| Q36184493 | Identification of a divergent M protein gene and an M protein-related gene family in Streptococcus pyogenes serotype 49 |
| Q34373919 | Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci |
| Q31109211 | Identification of a streptolysin S-associated gene cluster and its role in the pathogenesis of Streptococcus iniae disease |
| Q36357079 | Identification of an endogenous membrane anchor-cleaving enzyme for group A streptococcal M protein. Its implication for the attachment of surface proteins in gram-positive bacteria |
| Q38321957 | Identification of residues responsible for the defective virulence gene regulator Mga produced by a natural mutant of Streptococcus pyogenes |
| Q40151753 | Identification of two proteins associated with virulence of Streptococcus suis type 2. |
| Q35225082 | Identifying protective antigens of Staphylococcus aureus, a pathogen that suppresses host immune responses |
| Q33753390 | Identity and prevalence of multilocus sequence typing-defined clones of group A streptococci within a hospital setting |
| Q47666939 | Immune Cross-Opsonization Within emm Clusters Following Group A Streptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity. |
| Q34184513 | Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice |
| Q41986951 | Immunochemical localization and amino acid sequences of crossreactive epitopes within the group A streptococcal M6 protein |
| Q40913406 | Immunochemistry and end-group analyses of group A streptococcal M proteins |
| Q34121015 | Immunogenicity of a 26-valent group A streptococcal vaccine. |
| Q40278264 | Immunogenicity of a divalent group A streptococcal vaccine |
| Q40193823 | Immunologic and genetic comparison of Streptococcus equi isolates from the United States and Europe |
| Q33767819 | Impact of M49, Mrp, Enn, and C5a peptidase proteins on colonization of the mouse oral mucosa by Streptococcus pyogenes |
| Q71587113 | Impaired lymphocyte stimulation by some streptococcal antigens in patients with recurrent aphthous stomatitis and rheumatic heart disease |
| Q37000013 | Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. |
| Q36351366 | Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein |
| Q39964221 | Integration of bacteriophage SP24 into the chromosome of group A streptococci |
| Q67686712 | Intermediate Filaments Vimentin and Desmin Share Epitopes with M 1 Protein of Group A Streptococci |
| Q35784225 | International quality assurance study for characterization of Streptococcus pyogenes |
| Q37427385 | Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections. |
| Q34983585 | IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge |
| Q36204811 | Isolation and characterization of the cell-associated region of group A streptococcal M6 protein |
| Q31142981 | Large-scale screen highlights the importance of capsule for virulence in the zoonotic pathogen Streptococcus iniae |
| Q40247151 | Leukocytic hypersensitivity in experimental group A streptococcal infections. |
| Q39860288 | Localization of immunoglobulin A-binding sites within M or M-like proteins of group A streptococci |
| Q42938046 | Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein |
| Q42746939 | Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein |
| Q40643107 | Lymphocyte surface markers in acute rheumatic fever and post-streptococcal acute glomerulonephritis |
| Q55029549 | M Protein of Group a Streptococcus Plays an Essential Role in Inducing High Expression of A20 in Macrophages Resulting in the Downregulation of Inflammatory Response in Lung Tissue. |
| Q34473202 | M Protein-Associated Adherence of Streptococcus pyogenes to Epithelial Surfaces: Prerequisite for Virulence |
| Q40340242 | M protein and protein F act as important determinants of cell-specific tropism of Streptococcus pyogenes in skin tissue |
| Q35772760 | M protein mediates streptococcal adhesion to HEp-2 cells |
| Q33752194 | M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H |
| Q34067666 | M proteins of group A streptococci |
| Q30452551 | M proteins of group C streptococci isolated from patients with acute pharyngitis |
| Q34990045 | M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999. |
| Q34116464 | M(+) group a streptococci are phagocytized and killed in whole blood by C5a-activated polymorphonuclear leukocytes |
| Q31440381 | M-like proteins of Streptococcus dysgalactiae |
| Q30418506 | M-like, immunoglobulin-binding protein of Streptococcus pyogenes type M15. |
| Q35782330 | M12 protein from Streptococcus pyogenes is a receptor for immunoglobulin G3 and human albumin |
| Q40156140 | Mapping T-cell epitopes in group A streptococcal type 5 M protein |
| Q70829207 | Measuring resistance to phagocytosis of group A and G streptococci: comparison of direct bactericidal assay and flow cytometry |
| Q35539071 | Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses |
| Q34511612 | Mediation of cytotoxic effects of streptococcal M protein by nontype-specific antibody in human sera |
| Q34472351 | Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus |
| Q34176536 | Micro Complement Fixation Assay for Type-Specific Group A Streptococcal Antibody |
| Q33815105 | Microtiter Indirect Hemagglutination Procedure for Identification of Streptococcal M-Protein Antibodies |
| Q37361187 | Modified method for serological identification of group B streptococci |
| Q36891798 | Molecular analysis of group A streptococcal isolates associated with scarlet fever in southern Taiwan between 1993 and 2002 |
| Q35555808 | Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein |
| Q40161025 | Molecular analysis of the M protein of Streptococcus equi and cloning and expression of the M protein gene in Escherichia coli |
| Q37384284 | Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection |
| Q39534301 | Molecular aspects of the phagocytosis resistance of group A streptococci |
| Q36220784 | Molecular characterization and evaluation of the emerging antibiotic-resistant Streptococcus pyogenes from eastern India |
| Q26823667 | Molecular epidemiology and genomics of group A Streptococcus |
| Q40014251 | Molecular epidemiology of Streptococcus pyogenes in an area where acute pharyngotonsillitis is endemic |
| Q39705974 | Molecular genetic analysis of a group A Streptococcus operon encoding serum opacity factor and a novel fibronectin-binding protein, SfbX |
| Q37023910 | Monoclonal antibody to human renal glomeruli cross-reacts with streptococcal M protein |
| Q40167405 | Mucosal nasopharyngeal immune responses of horses to protein antigens of Streptococcus equi. |
| Q34145098 | Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes |
| Q36208963 | Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case. |
| Q24548700 | Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone |
| Q24564671 | Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures |
| Q33910815 | Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes |
| Q39831634 | Murine model of recurrent group G streptococcal cellulitis: no evidence of protective immunity. |
| Q37264797 | Natural variation in the promoter of the gene encoding the Mga regulator alters host-pathogen interactions in group a Streptococcus carrier strains |
| Q41188604 | Nephropathy in the rabbit associated with immunization to a group a streptococcal Lipoteichoic acid |
| Q36271083 | New approaches for the laboratory recognition of M types of group A streptococci |
| Q33851954 | New protective antigen of group A streptococci |
| Q34109633 | New streptococcal serotypes causing pyoderma and acute glomerulonephritis types 59,60, and 61. |
| Q31143435 | Non-immune binding of human IgG to M-related proteins confers resistance to phagocytosis of group A streptococci in blood |
| Q33631017 | Novel conserved group A streptococcal proteins identified by the antigenome technology as vaccine candidates for a non-M protein-based vaccine. |
| Q40148538 | Nucleotide sequences of two adjacent M or M-like protein genes of group A streptococci: different RNA transcript levels and identification of a unique immunoglobulin A-binding protein |
| Q36351849 | Opsonic antibodies evoked by hybrid peptide copies of types 5 and 24 streptococcal M proteins synthesized in tandem |
| Q33753988 | Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections |
| Q39746649 | PCR m typing: a new method for rapid typing of group a streptococci. |
| Q36357627 | Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A |
| Q29615547 | Pathogenesis of group A streptococcal infections |
| Q34108058 | Peptic digestion of streptococcal M protein. II. Extraction of M antigen from group A streptococci with pepsin |
| Q36966871 | Phenotypic diversity in the alpha C protein of group B streptococci. |
| Q35947405 | Platelet-Dependent Neutrophil Function Is Dysregulated by M Protein from Streptococcus pyogenes |
| Q37201383 | Population biology of the human restricted pathogen, Streptococcus pyogenes |
| Q40258664 | Potential coverage of a multivalent M protein-based group A streptococcal vaccine |
| Q35548993 | Preferential recognition of human myocardial antigens by T lymphocytes from rheumatic heart disease patients |
| Q37677979 | Presence of two distinct regions in the coiled-coil structure of the streptococcal Pep M5 protein: relationship to mammalian coiled-coil proteins and implications to its biological properties |
| Q38192121 | Preventing rheumatic fever: M-protein based vaccine |
| Q30353659 | Primary structure of streptococcal Pep M5 protein: Absence of extensive sequence repeats. |
| Q34112608 | Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections |
| Q40068749 | Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A Streptococci. |
| Q42940136 | Protective and heart-crossreactive epitopes located within the NH2 terminus of type 19 streptococcal M protein |
| Q34005434 | Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes. |
| Q36355029 | Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein |
| Q71834356 | Protective immunity to the group A Streptococcus may be only strain specific |
| Q36353910 | Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem |
| Q34509037 | Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteers |
| Q36277427 | Protein A-specific monoclonal antibodies and prevention of Staphylococcus aureus disease in mice |
| Q39510414 | Protein H, an antiphagocytic surface protein in Streptococcus pyogenes |
| Q35650206 | Puerperal fever and neonatal pleural empyema and bacteremia caused by group A streptococcus |
| Q40879801 | Purification and antigenicity of an M-like protein of Streptococcus equi. |
| Q34128905 | Purification and serological characterization of a type-specific antigen of Streptococcus equisimilis |
| Q34156384 | Pyelonephritis XI. Effect of Growth Phase of Streptococcus faecalis on Serum Susceptibility and Virulence |
| Q72632989 | Quantitation of M antigen in Lancefield extracts of group A streptococci type 12 using electro-immuno assay |
| Q38463338 | Reactivity of rheumatic fever and scarlet fever patients' sera with group A streptococcal M protein, cardiac myosin, and cardiac tropomyosin: a retrospective study |
| Q39823542 | Regulation of virulence by environmental signals in group A streptococci: influence of osmolarity, temperature, gas exchange, and iron limitation on emm transcription |
| Q37680923 | Relationship of M protein genes in group A streptococci |
| Q30481807 | Relationships between emm and multilocus sequence types within a global collection of Streptococcus pyogenes |
| Q35533328 | Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus. |
| Q33582935 | Renal autoimmune epitope of group A streptococci specified by M protein tetrapeptide Ile-Arg-Leu-Arg |
| Q34006146 | Restoration of Mga function to a Streptococcus pyogenes strain (M Type 50) that is virulent in mice |
| Q36722011 | Restricted association between biotypes and serotypes within group A streptococci |
| Q40269065 | Rheumatic fever pathogenesis: Approach in research needs change |
| Q36963706 | Role of M protein in adherence of group A streptococci |
| Q33598757 | Role of M protein in pharyngeal colonization by group A streptococci in rats |
| Q39077444 | Role of fibrinogen in complement inhibition by streptococcal M protein |
| Q37427591 | Role of macrophages in host resistance to group A streptococci |
| Q35628204 | Role of mga in growth phase regulation of virulence genes of the group A streptococcus |
| Q35545719 | Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia. |
| Q30833365 | Role of serotype-specific polysaccharide in the resistance of Streptococcus mutans to phagocytosis by human polymorphonuclear leukocytes |
| Q34005021 | Role of streptolysin O in a mouse model of invasive group A streptococcal disease |
| Q36266432 | STREPTOCOCCAL M ANTIGEN LOCATION AND SYNTHESIS, STUDIED BY IMMUNOFLUORESCENCE |
| Q26852214 | Sec-secretion and sortase-mediated anchoring of proteins in Gram-positive bacteria |
| Q37222605 | Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides |
| Q33809696 | Secondary and apparent primary antibody responses after group A streptococcal vaccination of 21 children |
| Q40717648 | Separation of the Proteolytic and Streptolytic Components of a Streptomyces albus Enzyme Preparation and Their Effect on Streptococcal Cells |
| Q24672374 | Sequence and structural characteristics of the trypsin-resistant T6 surface protein of group A streptococci |
| Q42938590 | Sequence of myosin-crossreactive epitopes of streptococcal M protein |
| Q34063290 | Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci |
| Q34971503 | Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece |
| Q34064236 | Signal transduction through CsrRS confers an invasive phenotype in group A Streptococcus. |
| Q37237224 | Simplified method for the purification of group A streptococcal M-proteins: solution of the multiple banding problem. |
| Q47196403 | Size variation in group A streptococcal M protein is generated by homologous recombination between intragenic repeats |
| Q36350086 | Size variation of the M protein in group A streptococci |
| Q54218671 | Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy. |
| Q64271888 | Sortases, Surface Proteins, and Their Roles in Disease and Vaccine Development |
| Q34007193 | Spa contributes to the virulence of type 18 group A streptococci |
| Q39839170 | Specific binding of the activator Mga to promoter sequences of the emm and scpA genes in the group A streptococcus. |
| Q33665979 | Spontaneous M6 protein size mutants of group A streptococci display variation in antigenic and opsonogenic epitopes |
| Q26798461 | Staphylococcal manipulation of host immune responses |
| Q39513619 | Strain-specific restriction of the antiphagocytic property of group A streptococcal M proteins |
| Q36233908 | Streptococcal Immunity Is Constrained by Lack of Immunological Memory following a Single Episode of Pyoderma. |
| Q42938486 | Streptococcal M protein size mutants occur at high frequency within a single strain |
| Q30382858 | Streptococcal M protein: molecular design and biological behavior. |
| Q36348692 | Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein |
| Q30301331 | Streptococcal pharyngitis in schoolchildren in Bamako, Mali |
| Q33513502 | Streptococcal protective antigens (Spa): a new family of type-specific proteins of group A streptococci. |
| Q40390843 | Streptococcal pyrogenic exotoxin B causes mitochondria damage to polymorphonuclear cells preventing phagocytosis of group A streptococcus. |
| Q40149945 | Streptococcal rheumatic carditis |
| Q33497167 | Streptococcal toxic shock-like syndrome. Report of two cases from Italy. |
| Q24648318 | Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment |
| Q34194001 | Streptococcus dysgalactiae subsp. equisimilis Bacteremia, Finland, 1995-2004. |
| Q33355994 | Streptococcus iniae M-like protein contributes to virulence in fish and is a target for live attenuated vaccine development |
| Q34006623 | Streptococcus iniae virulence is associated with a distinct genetic profile |
| Q35814379 | Streptococcus pyogenes Sortase Mutants Are Highly Susceptible to Killing by Host Factors Due to Aberrant Envelope Physiology |
| Q92049359 | Streptococcus pyogenes evades adaptive immunity through specific IgG glycan hydrolysis |
| Q35780115 | Streptococcus uberis resists the bactericidal action of bovine neutrophils despite the presence of bound immunoglobulin |
| Q35064234 | Structural vaccinology to thwart antigenic variation in microbial pathogens |
| Q38264670 | Structure and Interactions of a Dimeric Variant of sHIP, a Novel Virulence Determinant of Streptococcus pyogenes |
| Q40880980 | Studies on Gonococcus infection. IX. In vitro decreased assocation of pilated gonococci with mouse peritoneal macrophages |
| Q33538951 | Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope |
| Q40024780 | Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. |
| Q95751084 | Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice |
| Q36267466 | THE LYSIS OF CELL WALLS OF GROUP A STREPTOCOCCI BY STREPTOMYCES ALBUS ENZYME TREATED WITH DIISOPROPYL FLUOROPHOSPHATE. CHARACTERISTICS OF THE LYTIC REACTION AND THE SOLUBLE CELL WALL FRAGMENTS. |
| Q33719247 | TYPE-SPECIFIC STREPTOCOCCAL IMMUNIZATION WITH ORAL VACCINE |
| Q35899072 | Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation |
| Q33793995 | The M protein is dispensable for maturation of streptococcal cysteine protease SpeB. |
| Q46135931 | The amino-terminal region of group A streptococcal M protein determines its molecular state of assembly and function |
| Q67582426 | The group A streptococcal M-type 3 protein gene exhibits a C terminus typical for class I M proteins |
| Q36354665 | The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci |
| Q36379227 | The multiple molecular structure of the M proteins of group A streptococci |
| Q39146442 | The prospect of vaccination against group A beta-hemolytic streptococci |
| Q42835089 | The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man. |
| Q92090415 | Tissue Tropism in Streptococcal Infection: Wild-Type M1T1 Group A Streptococcus Is Efficiently Cleared by Neutrophils Using an NADPH Oxidase-Dependent Mechanism in the Lung but Not in the Skin |
| Q41928281 | Towards developing a vaccine for rheumatic heart disease |
| Q36271194 | Toxic effects of streptococcal M protein on platelets and polymorphonuclear leukocytes in human blood |
| Q36343372 | Tropomyosin-like seven residue periodicity in three immunologically distinct streptococal M proteins and its implications for the antiphagocytic property of the molecule |
| Q37596180 | Two distinct genotypes of prtF2, encoding a fibronectin binding protein, and evolution of the gene family in Streptococcus pyogenes. |
| Q37204165 | Two major classes in the M protein family in group A streptococci |
| Q39610618 | Type-Specific and Non-Type-Specific Reactions of Purified M Protein Preparations |
| Q34491043 | Type-specific inhibition of preopsonization versus immunoprecipitation by Streptococcal M proteins. |
| Q35100210 | Ultrastructural localization of the fibrinogen-binding domain of streptococcal M protein. |
| Q37031198 | Unimpaired function of human phagocytes in the presence of phagocytosis-resistant group A streptococci |
| Q30586381 | Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection. |
| Q35130822 | Vaccine assembly from surface proteins of Staphylococcus aureus. |
| Q34211635 | Vaccinia virus vectors: new strategies for producing recombinant vaccines |
| Q33962937 | Variation in Streptococcus pyogenes NAD+ glycohydrolase is associated with tissue tropism |
| Q35100488 | Vimentin-cross-reactive epitope of type 12 streptococcal M protein. |
| Q40270053 | Virulence of two Streptococcus pyogenes strains (types M1 and M3) associated with toxic-shock-like syndrome depends on an intact mry-like gene |
| Q67474974 | Virulence properties of erysipelas-associated group A streptococci |
| Q36351482 | Vitamin D and the human antimicrobial peptide LL-37 enhance group a streptococcus resistance to killing by human cells |
| Q29248567 | YvqE and CovRS of Group A Streptococcus Play a Pivotal Role in Viability and Phenotypic Adaptations to Multiple Environmental Stresses |
| Q54024014 | [On the occurrence of beta-hemolytic streptococci in the oropharynx in Bonn school children]. |
| Q39735550 | emm Gene distribution among erythromycin-resistant and -susceptible Italian isolates of Streptococcus pyogenes |
| Q94606194 | emm Types and clusters and macrolide resistance of pediatric group A streptococcal isolates in Central Greece during 2011-2017 |
| Q37302090 | emm and C-repeat region molecular typing of beta-hemolytic Streptococci in a tropical country: implications for vaccine development |
Search more.